OR WAIT null SECS
May 01, 2008
The pharmaceutical industry must address the release of nonbiodegradable APIs into the environment.
April 02, 2008
A changing regulatory environment is on the horizon for excipient suppliers and users.
Moderate growth is projected for the global excipients market. Excipient producers target blends and new grades for improving functionality and performance.
Excipient producers and industry observers share their perspectives on innovation for excipients.
What makes a drug ripe for respiratory delivery?
March 02, 2008
Mannitol is the most commonly used bulking agent in freeze-drying formulation design. The benefit of using mannitol is that it crystallizes during freezing and permits drying processes at higher product temperatures, and thus with higher sublimation rates relative to purely amorphous systems (1). Mannitol, however, is known to form different crystalline modifications which compromises reproducibility of product characteristics and storage stability due to phase transformations (2, 3).
The European Union's REACH initiative has the potential to affect the flow of chemicals into the pharmaceutical suppy chain.
February 14, 2008
Scientists at The Wistar Institute are taking further steps into understanding a gene regulator that can lead them closer to developing new cancer therapies.
February 02, 2008
Contract manufacturers expand capabilities in aseptic processing, clinical-trial materials supply, and cytotoxic manufacturing.
An updated book summarizes recent research for formulators and drug-delivery specialists.